Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer.

Cancers (Basel) · 2021 · PMC7864165 · PMID 33498535

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

showed a trendp = 0.08so close (0.05 < p ≤ 0.1)

Patients treated with ablative dose are less likely to develop recurrence (adjusted HR 0.54, p = 0.01) and ablative dose showed a trend towards better CR at six months significant (adjusted OR 0.49, p = 0.08).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.